Back

Potassium binders.

30 April 2017 (09:24 - 09:42)
Organised by:
Congress Presentation Part of: Novel drugs: how do they work? Diuretics HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Professor Bertram Pitt

University of Michigan, Ann Arbor (United States of America)

4 More presentations in this session

Presentation thumbnail
Neprilysin inhibition.
Doctor N. Vodovar (Paris, FR)
Slides Video
Presentation thumbnail
Empaglifozin (SGLT-2 inhibition).
Professor N. Marx (Aachen, DE)
Slides Video
Presentation thumbnail
Serelaxin
Professor J. Teerlink (San Francisco, US)
Slides Video
Presentation thumbnail
Beta-3 Agonists.
Professor J. Balligand (Brussels, BE)
Slides Video

Access the full session

Session thumbnail
Novel drugs: how do they work?

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

30 April 2017 09:24 CET
You may be interested in
thumbnail
Congress Presentation
Meta-analysis on the role of potassium binders in optimization of guideline-directed medical therapy and safety outcomes in patients with heart failure
20 May 2023
thumbnail
Webinar
What every clinician should know about antiarrhythmic drugs: insights from the 2025 EHRA Compendium
9 September 2025
thumbnail
Congress Presentation
Proportion of patients taking indapamide developing severe hypokalaemia
27 August 2021
thumbnail
Congress Session
Does aldosterone synthase inhibition hold a key to transforming cardiorenal care?
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources